Price movement over the last 24 hours
Align Technology, Inc. vs Prudential PLC — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while Prudential PLC trades at $28.23 (market cap $34.34B). The key difference: Prudential PLC is far larger — about 2.7× Align Technology, Inc.'s market cap, and Prudential PLC pays a 1.89% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ALGN | PUK | |
|---|---|---|
Market Cap | $12.86B | $34.34B |
Sector | Health | Financials |
52-Week High | $207.19 | $33.61 |
52-Week Low | $124.88 | $24.65 |
Enterprise Value | $11.92B | $35.78B |
Dividend Yield | — | 1.89% |
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
Prudential Financial (PUK) trades at $28.13, up 1.33% with a bullish technical signal. The stock shows strong fundamentals with a P/E of 9.16, net income margin of 14.52%, and recent earnings beats. Revenue grew to $16.21B in 2024, with net income reaching $2.29B. Analyst consensus is 50% buy, 37.5% hold, and 12.5% sell. Recent news highlights Q2 2026 earnings anticipation and strategic moves in India.
Outlook is positive with robust profitability and valuation appeal, but risks include Japan sales suspension and regulatory scrutiny. The stock offers growth potential from international expansion, supported by solid cash flow and equity performance. Investors should weigh near-term headwinds against long-term strategic positioning.
Trailing returns across standard periods
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →Prudential is an Asia and Africa health and life insurance business and is focused on long-term savings. The business is increasingly focusing on digital offerings and creating strong brand equity and relationships with customers of its products through these.
Read more on PUK →